Hajime Nagasu
Overview
Explore the profile of Hajime Nagasu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
913
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takasu M, Kishi S, Nagasu H, Kidokoro K, Brooks C, Kashihara N
Kidney Int Rep
. 2025 Feb;
10(2):328-342.
PMID: 39990900
Diabetic kidney disease (DKD) is recognized worldwide as a leading cause of end-stage renal failure. Although therapies that target glomerular hemodynamics and can inhibit disease progression have been developed, there...
2.
Ohashi M, Ishikawa Y, Arai S, Nagao T, Kitaoka K, Nagasu H, et al.
Clin Exp Nephrol
. 2025 Jan;
PMID: 39813007
Background: Chronic kidney disease (CKD) represents a significant public health challenge, with rates consistently on the rise. Enhancing kidney function prediction could contribute to the early detection, prevention, and management...
3.
Suzuki T, Nagasu H, Ebara T, Kagiyama N, Kishi T, Yano Y, et al.
Intern Med
. 2024 Dec;
PMID: 39631859
Digital health, which encompasses digital medicine and therapy, integrates advanced technologies across healthcare. Central to this transformation is 'digitization,' which converts continuous analog data into a discrete digital form. However,...
4.
Shimamoto S, Nakahara T, Yamada S, Nagasu H, Kishi S, Nakashima N, et al.
Sci Rep
. 2024 Nov;
14(1):27481.
PMID: 39523380
Chronic kidney disease-mineral and bone disorder (CKD-MBD) are recognized as a systemic disease affecting the prognosis of patients with CKD. Proper management of CKD-MBD is important to improve the prognosis...
5.
6.
Kajimoto E, Nagasu H, Takasu M, Kishi S, Wada M, Tatsugawa R, et al.
Sci Rep
. 2024 Nov;
14(1):26438.
PMID: 39488570
Diabetic kidney disease (DKD) is a major disease characterized by early albuminuria and heightened risk of renal deterioration. Increased reactive oxygen species (ROS) production, especially in glomeruli, plays an important...
7.
Hirano A, Kadoya H, Takasu M, Iwakura T, Kajimoto E, Tatsugawa R, et al.
Microcirculation
. 2024 Sep;
31(8):e12889.
PMID: 39348278
Objective: Endothelial dysfunction plays an important role in the pathogenesis of chronic kidney disease. Prostacyclin (PGI), an endothelial cell-produced endogenous prostaglandin, plays a crucial role in maintaining endothelial function. However,...
8.
Kitaoka K, Yano Y, Nagasu H, Kanegae H, Chishima N, Akiyama H, et al.
BMJ Open Diabetes Res Care
. 2024 May;
12(3).
PMID: 38816204
Introduction: We compared the kidney outcomes between patients with diabetic kidney disease (DKD) aged ≥75 years initiating sodium-glucose cotransporter 2 (SGLT2) inhibitors versus other glucose-lowering drugs, additionally presenting with or...
9.
Wada Y, Kidokoro K, Kondo M, Tokuyama A, Kadoya H, Nagasu H, et al.
Kidney Int
. 2024 May;
106(3):408-418.
PMID: 38801992
The mechanisms responsible for glomerular hemodynamic regulation with sodium-glucose co-transporter 2 (SGLT2) inhibitors in kidney disease due to type 2 diabetes remain unclear. Therefore, we investigated changes in glomerular hemodynamic...
10.
Nyma Z, Kitaoka K, Yano Y, Kanegae H, Bayaraa N, Kishi S, et al.
Sci Rep
. 2024 May;
14(1):11481.
PMID: 38769367
Understanding the association between compliance to the Chronic Kidney Disease (CKD) guidelines in real-world clinical settings and renal outcomes remains a critical gap in knowledge. A comprehensive analysis was conducted...